Newmont executive sells 8,060 shares in planned trade
NEWMONT Corp executive David John Thornton, MD, Americas, reported an open-market sale of common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
NEWMONT Corp executive David John Thornton, MD, Americas, reported an open-market sale of common stock. On March 3, 2026, he sold 8,060 shares of Newmont common stock at an average price of $120.78 per share, and now holds 27,264 shares directly.
The transaction was carried out under a pre-established Rule 10b5-1 trading plan dated December 1, 2025, indicating it was scheduled in advance rather than decided at the time of sale.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock, $1.60 par value | 8,060 | $120.78 | $973K |
Footnotes (1)
- F1. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan dated December 1, 2025
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did NEWMONT (NEM) report for David John Thornton?
Was the NEWMONT (NEM) insider sale by David John Thornton under a 10b5-1 plan?
What role does David John Thornton hold at NEWMONT (NEM)?
AI-generated analysis. How Rhea-AI works. Not financial advice.